Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hepatosplenic alphabeta T cell lymphoma.
Nagai Y, Ikegame K, Mori M, Inoue D, Kimura T, Shimoji S, Togami K, Tabata S, Kurata M, Imai Y, Matsushita A, Nagai K, Ogawa H, Takahashi T. Nagai Y, et al. Among authors: ikegame k. Int J Clin Oncol. 2010 Apr;15(2):215-9. doi: 10.1007/s10147-010-0028-y. Epub 2010 Mar 10. Int J Clin Oncol. 2010. PMID: 20217452
Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers.
Oji Y, Miyoshi S, Maeda H, Hayashi S, Tamaki H, Nakatsuka S, Yao M, Takahashi E, Nakano Y, Hirabayashi H, Shintani Y, Oka Y, Tsuboi A, Hosen N, Asada M, Fujioka T, Murakami M, Kanato K, Motomura M, Kim EH, Kawakami M, Ikegame K, Ogawa H, Aozasa K, Kawase I, Sugiyama H. Oji Y, et al. Among authors: ikegame k. Int J Cancer. 2002 Jul 20;100(3):297-303. doi: 10.1002/ijc.10476. Int J Cancer. 2002. PMID: 12115544
Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis.
Oka Y, Tsuboi A, Murakami M, Hirai M, Tominaga N, Nakajima H, Elisseeva OA, Masuda T, Nakano A, Kawakami M, Oji Y, Ikegame K, Hosen N, Udaka K, Yasukawa M, Ogawa H, Kawase I, Sugiyama H. Oka Y, et al. Among authors: ikegame k. Int J Hematol. 2003 Jul;78(1):56-61. doi: 10.1007/BF02983241. Int J Hematol. 2003. PMID: 12894852 Clinical Trial.
Monitoring minimal residual disease in leukemia using real-time quantitative polymerase chain reaction for Wilms tumor gene (WT1).
Tamaki H, Mishima M, Kawakami M, Tsuboi A, Kim EH, Hosen N, Ikegame K, Murakami M, Fujioka T, Masuda T, Taniguchi Y, Nishida S, Osumi K, Soma T, Oji Y, Oka Y, Kawase I, Sugiyama H, Ogawa H. Tamaki H, et al. Among authors: ikegame k. Int J Hematol. 2003 Nov;78(4):349-56. doi: 10.1007/BF02983561. Int J Hematol. 2003. PMID: 14686494
Impact of cytogenetics on outcome of stem cell transplantation for acute myeloid leukemia in first remission: a large-scale retrospective analysis of data from the Japan Society for Hematopoietic Cell Transplantation.
Ogawa H, Ikegame K, Kawakami M, Takahashi S, Sakamaki H, Karasuno T, Sao H, Kodera Y, Hirabayashi N, Okamoto S, Harada M, Iwato K, Maruta A, Tanimoto M, Kawa K; Japan Society for Hematopoietic Cell Transplantation. Ogawa H, et al. Among authors: ikegame k. Int J Hematol. 2004 Jun;79(5):495-500. doi: 10.1532/ijh97.03166. Int J Hematol. 2004. PMID: 15239403
209 results